Healthcare
Digital migraine treatment devices market to hit $298.7m by 2030
Digital migraine treatment devices market to hit $298.7m by 2030
Hospitals remained the leading end-user in 2024.
Southeast Asia health tech funding rebounds to $108m in H1
Deal activity doubled to 16.
APAC eyes fastest growth in global home healthcare market
It is projected to expand at a CAGR of 10.1%.
Vaccines market to be valued at $63.7b by 2030
Its expansion is attributed to rapid development and commercialisation.
Digital pathology market to be valued at $1.91b by 2032
Thanks to the increasing need for healthcare access in rural areas.
Ciputra Mitra Hospital speeds up heart and stroke response
Once a patient arrives, heart or stroke codes are triggered instantly.
Alternative cancer treatment market to hit $2.16b by 2030
Rising cancer incidence and survivorship rates drive complementary therapies.
8MM Alzheimer’s disease market to hit $17b by 2033
Disease-modifying therapies are expected to account for 69.2% of the market.
Self-monitoring blood glucose device market to triple by 2034
By end-users, the home care segment is expected to witness the fastest growth.
Global contraceptive drugs and devices market to reach $75b by 2035
Thanks to a rising awareness about family access.
Emerging markets to see mixed health spending growth
India and Turkiye are experiencing sharp increases in expenditure.
Diagnostics M&A activity to stay subdued in H2 amidst tariff uncertainty
Deal volume slowed after the first quarter.
Surgical sutures market to be valued at $6.65b by 2030
Thanks to a rise in surgical interventions driven by an ageing population.
7MM hidradenitis suppurativa market to quadruple by 2034
Thanks to the approval and uptake of next-generation biologics.
Biologic therapeutic market to hit $794.5b by 2029
Thanks to the demand for monoclonal antibodies, gene and cell therapies, and vaccines.
What lies ahead for Taiwan’s neurosurgery robotic surgical systems market?
The sector is driven by the increasing demand for minimally invasive procedures.
China leads in clinical trials outside North America and Europe in Q2
Meanwhile, India overtook Iran to claim second place.
Commentary
Fluid licence on affiliated companies: An explorative strategy to consolidate Indonesia’s telecom industry
From alps to algorithms: Why Asia must wake up to Switzerland’s Deep Tech Surge